Related Experiment Video

Updated: Sep 23, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1

Ching-Ching Ng1, Hirofumi Arakawa, Seisuke Fukuda

  • 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

Oncogene
|July 11, 2003
PubMed

Insights

Researchers discovered a new protein, p53RFP (p53-inducible RING-finger protein), that acts as an E3 ubiquitin ligase. This finding reveals a novel mechanism for p53 in regulating cell-cycle checkpoints by controlling p21(WAF1) protein stability.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The tumor suppressor protein p53 plays a critical role in preventing cancer through various mechanisms, including cell-cycle arrest and apoptosis.
  • p53 regulates gene expression, influencing the levels of numerous proteins involved in cellular processes.
  • Understanding p53's regulatory network is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To identify novel transcriptional targets of p53 involved in cancer prevention.
  • To characterize the function and regulatory role of a newly identified p53 target, p53RFP.
  • To elucidate a potential new mechanism for p53-mediated cell-cycle control.

Main Methods:

  • Isolation and characterization of a novel p53 transcriptional target, p53RFP.
  • Analysis of the enzymatic activity of p53RFP, identifying it as an E3 ubiquitin ligase.
  • Investigation of the relationship between p53RFP and p21(WAF1) protein expression and interaction.
  • Comparison of p53RFP with known p53 targets like MDM2.

Main Results:

  • A novel p53-inducible RING-finger protein (p53RFP) with E3 ubiquitin ligase activity was identified.
  • p53RFP expression showed an inverse correlation with p21(WAF1) protein levels.
  • p53RFP potentially regulates p21(WAF1) stability through ubiquitination.
  • p53RFP is the second identified E3 ubiquitin ligase, following MDM2, to be a direct transcriptional target of p53.

Conclusions:

  • p53RFP represents a novel E3 ubiquitin ligase regulated by p53.
  • p53 may control p21(WAF1) stability via transcriptional regulation of p53RFP.
  • This pathway offers a new perspective on p53-dependent cell-cycle checkpoint regulation in cancer prevention.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...